KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $750.6 million.

  • Biogen's Other Non-Current Assets rose 3391.61% to $750.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $750.6 million, marking a year-over-year increase of 3391.61%. This contributed to the annual value of $750.6 million for FY2025, which is 3391.61% up from last year.
  • Biogen's Other Non-Current Assets amounted to $750.6 million in Q4 2025, which was up 3391.61% from $729.7 million recorded in Q3 2025.
  • Over the past 5 years, Biogen's Other Non-Current Assets peaked at $2.5 billion during Q2 2021, and registered a low of $559.1 million during Q1 2025.
  • Over the past 5 years, Biogen's median Other Non-Current Assets value was $929.8 million (recorded in 2023), while the average stood at $1.2 billion.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 11431.1% in 2021, then tumbled by 5320.6% in 2023.
  • Quarter analysis of 5 years shows Biogen's Other Non-Current Assets stood at $1.9 billion in 2021, then fell by 21.15% to $1.5 billion in 2022, then tumbled by 51.28% to $745.0 million in 2023, then decreased by 24.77% to $560.5 million in 2024, then surged by 33.92% to $750.6 million in 2025.
  • Its last three reported values are $750.6 million in Q4 2025, $729.7 million for Q3 2025, and $637.7 million during Q2 2025.